A phase I/II study of antibody targeted therapy with CDP671/1 in advanced non-small cell lung cancer (NSCLC)

P Lorigan; J Carmichael; P.J Woll; K O'Byrne; S Browne; M Sopwith

doi:10.1016/s0169-5002(00)80172-5

A phase I/II study of antibody targeted therapy with CDP671/1 in advanced non-small cell lung cancer (NSCLC)

P Lorigan, J Carmichael, P.J Woll, K O'Byrne, S Browne, M Sopwith

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	53
Journal	Lung Cancer
Volume	29
Issue number	1
DOIs	https://doi.org/10.1016/s0169-5002(00)80172-5
Publication status	Published - Sept 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s0169-5002(00)80172-5

Cite this

@article{8b86362cf5324e4d83e327387249513b,

title = "A phase I/II study of antibody targeted therapy with CDP671/1 in advanced non-small cell lung cancer (NSCLC)",

author = "P Lorigan and J Carmichael and P.J Woll and K O'Byrne and S Browne and M Sopwith",

year = "2000",

month = sep,

doi = "10.1016/s0169-5002(00)80172-5",

language = "English",

volume = "29",

pages = "53",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier BV",

number = "1",

}

TY - JOUR

T1 - A phase I/II study of antibody targeted therapy with CDP671/1 in advanced non-small cell lung cancer (NSCLC)

AU - Lorigan, P

AU - Carmichael, J

AU - Woll, P.J

AU - O'Byrne, K

AU - Browne, S

AU - Sopwith, M

PY - 2000/9

Y1 - 2000/9

UR - http://www.mendeley.com/research/phase-iii-study-antibody-targeted-therapy-cdp6711-advanced-nonsmall-cell-lung-cancer-nsclc

U2 - 10.1016/s0169-5002(00)80172-5

DO - 10.1016/s0169-5002(00)80172-5

M3 - Article

SN - 0169-5002

VL - 29

SP - 53

JO - Lung Cancer

JF - Lung Cancer

IS - 1

ER -

A phase I/II study of antibody targeted therapy with CDP671/1 in advanced non-small cell lung cancer (NSCLC)

UN SDGs

Access to Document

Other files and links

Cite this